QMDT (QMDT) Stock Price & Analysis
QMDT (QMDT) rose 0.00% to USD 0 as of June 10, 2026 at 13:02 UTC, according to Nexqual real-time market data.
QMDT last closed at USD 0; the session ranged USD 0–0 on volume of 135,000 shares. Market capitalization is $29,876, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 13:02 UTC.
Key Statistics (as of June 10, 2026 at 13:02 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 135,000 shares |
| Market Cap | $29,876 |
| Exchange | PNK |
Technical Analysis (QMDT)
Nexqual's technical model rates QMDT "NEUTRAL" based on 3 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 13:02 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
| MACD | 0 (positive) |
Analyst Ratings (QMDT)
Wall Street analysts rate QMDT "None", per Nexqual as of June 10, 2026 at 13:02 UTC.
| Consensus Rating | None |
|---|
Earnings (QMDT)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2011-12-31 | USD -0.01 vs est -0.01 ▲ beat |
| 2011-09-30 | USD -0.01 vs est -0.01 ▲ beat |
| 2011-06-30 | USD -0.03 vs est -0.01 ▼ miss |
Source: Nexqual, June 10, 2026 at 13:02 UTC.
Financials & Fundamentals (QMDT)
| Total Revenue | $928,493 |
|---|---|
| Revenue Growth (YoY) | -27.40% |
| Gross Margin | +13.80% |
| Operating Margin | -77.01% |
| Profit Margin | -76.80% |
| Current Ratio | 0.04 |
| Total Cash | $49,677 |
| Total Debt | $7.91M |
| Free Cash Flow | $-1.29M |
Source: Nexqual, June 10, 2026 at 13:02 UTC.
Financial Health Score (QMDT)
Nexqual rates QMDT's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 13:02 UTC.
| Growth | Critical — Revenue -27% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $50K cash vs $8M debt |
| Cash Flow | Weak — FCF negative: -$1M, burning cash |
| Efficiency | Mixed — No data |
Ownership (QMDT)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 37.35M |
Source: Nexqual, June 10, 2026 at 13:02 UTC.
Leadership (QMDT)
QMDT is led by Gregory S. Schultz (age 75), Chairman & Scientific Advisor, per Nexqual as of June 10, 2026 at 13:02 UTC.
| Chairman & Scientific Advisor | Gregory S. Schultz (age 75) |
|---|---|
| Principal Executive Officer, President & Director | Bernd Liesenfeld (age 55) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NPHC | Nutra Pharma Corp. | USD 0 | ▲ 0% |
| RGIN | REGENICIN INC | USD 0 | ▲ 0% |
| AOLS | AEOLUS PHARMACEUTICALS INC | USD 0 | ▲ 0% |
| HMGN | HEMAGEN DIAGNOSTICS INC | USD 0 | ▲ 0% |
| IYXI | INYX INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 13:02 UTC. This page is informational and not investment advice.